美国 · SEC FORM 4
Niagen Bioscience, Inc.
NAGE · Nasdaq · CIK 0001386570 · Healthcare · Packaged Foods
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
4 同一窗口内观察到的 Form 4 交易行
0 sales · 4 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-11-14 · Pamir Ozan.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 3,874,102
- 上期报告
- 3,996,318
- 日均成交量
- 392,984
- 回补天数
- 9.9
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-11-14 | Pamir Ozan | 买入 (P) | Common Stock | 6,685 | USD 6.82 | USD 45,616 | SEC 申报 ↗ |
| 2025-03-07 | Lopez Carlos Luis | 买入 (P) | Common Stock | 273 | USD 7.86 | USD 2,146 | SEC 申报 ↗ |
| 2024-11-22 | Pamir Ozan | 买入 (P) | Common Stock | 2,907 | USD 7.36 | USD 21,397 | SEC 申报 ↗ |
| 2024-08-20 | Brilliant Dynasty Ltd; Champion River Ventures Ltd; Chau Hoi Shuen Solina Holly; Dvorak International Ltd; Elgar International Ltd; Pioneer Step Holdings Ltd; Radiant Treasure Ltd; Skyinvest Associates Ltd; Winsave Resources Ltd | 买入 (P) | Common Stock | 11,408,715 | USD — | USD — | SEC 申报 ↗ |
| 2023-12-01 | Gerber Brianna | 买入 (P) | Common Stock | 5,000 | USD 1.41 | USD 7,050 | SEC 申报 ↗ |
| 2023-09-06 | Champion River Ventures Ltd; Mayspin Management Ltd; Prime Tech Global Ltd; SHING LI KA | 买入 (P) | Common Stock | 3,467,778 | USD — | USD — | SEC 申报 ↗ |
| 2023-06-12 | Jaksch Frank L Jr | 买入 (P) | Common Stock | 7,000 | USD 1.69 | USD 11,830 | SEC 申报 ↗ |
| 2023-05-31 | Fried Robert N | 买入 (P) | Common Stock | 7,000 | USD 1.42 | USD 9,940 | SEC 申报 ↗ |
| 2023-05-25 | Rubin Steven D | 买入 (P) | Common Stock | 7,000 | USD 1.46 | USD 10,220 | SEC 申报 ↗ |
| 2022-09-30 | Fried Robert N | 买入 (P) | Common Stock | 80,000 | USD 1.25 | USD 100,000 | SEC 申报 ↗ |
| 2022-09-30 | Chau Hoi Shuen Solina Holly; Dvorak International Ltd; Pioneer Step Holdings Ltd | 买入 (P) | Common Stock | 960,000 | USD 1.25 | USD 1,200,000 | SEC 申报 ↗ |
| 2022-06-16 | Chau Hoi Shuen Solina Holly; Dvorak International Ltd; Pioneer Step Holdings Ltd | 买入 (P) | Common Stock | 60,037 | USD 1.66 | USD 99,661 | SEC 申报 ↗ |
| 2022-03-16 | Fried Robert N | 买入 (P) | Common Stock | 25,000 | USD 2.16 | USD 54,000 | SEC 申报 ↗ |
| 2021-05-13 | Fried Robert N | 买入 (P) | Common Stock | 10,000 | USD 6.65 | USD 66,500 | SEC 申报 ↗ |
| 2020-11-06 | FARR KEVIN M | 买入 (P) | Common Stock | 5,000 | USD 4.43 | USD 22,150 | SEC 申报 ↗ |
Form 4 申报证据
6 transaction lines in the latest 365-day window; 36 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | Pamir Ozan | 奖励／授予 (A) | Common Stock | 4,255 | USD 2.71 | USD 11,531 | SEC 申报 ↗ |
| 2026-06-30 | Lopez Carlos Luis | 奖励／授予 (A) | Common Stock | 2,314 | USD 2.71 | USD 6,271 | SEC 申报 ↗ |
| 2026-06-30 | Fried Robert N | 奖励／授予 (A) | Common Stock | 1,106 | USD 2.71 | USD 2,997 | SEC 申报 ↗ |
展开近期 Form 4 证据 (5 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | Pamir Ozan | 奖励／授予 (A) | Common Stock | 4,255 | USD 2.71 | USD 11,531 | SEC 申报 ↗ |
| 2026-06-30 | Lopez Carlos Luis | 奖励／授予 (A) | Common Stock | 2,314 | USD 2.71 | USD 6,271 | SEC 申报 ↗ |
| 2026-06-30 | Fried Robert N | 奖励／授予 (A) | Common Stock | 1,106 | USD 2.71 | USD 2,997 | SEC 申报 ↗ |
| 2026-04-24 | Fried Robert N | 期权行权／转换 (M) | Common Stock | 20,000 | USD 2.61 | USD 52,200 | SEC 申报 ↗ |
| 2025-11-14 | Pamir Ozan | 买入 (P) | Common Stock | 6,685 | USD 6.82 | USD 45,616 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | NAGE |
| CIK | 0001386570 |
| 行业 | Healthcare |
| 细分行业 | Packaged Foods Yahoo Finance |
| SEC SIC | 2833 Medicinal Chemicals & Botanical Products |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 36 transaction lines from 2020-04-17 to 2026-06-30 17 P purchase lines · 6 S sale lines · 13 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.